DMD
Pipeline by Development Stage
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (3)
Total enrollment: 148 patients across 3 trials
Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 Skipping
A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy.
Defining Outcome Measures for Behavioural and Emotional Problems in Dystrophinopathies
Related Jobs
Associate Director, Clinical Operations Study Lead
Material Handler
Senior Research Associate, Histology & Microscopy
Senior Director, Sponsor Oversight and Monitoring Effectiveness
Director, Oligonucleotide Manufacturing
Associate Director, Analytical Development
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.